BLB Solicitors
  • +01225 755656
  • enquiries@blbsolicitors.co.uk
BLB Solicitors
  • +01225 755656
  • enquiries@blbsolicitors.co.uk
  • Home
  • Services for You
    • Conveyancing Solicitors
    • Leasehold Solicitors
    • Property Dispute Solicitors
    • Divorce, Family Law and Mediation
    • Lifetime Planning and Wills
    • Probate and Estate Administration
    • Equity Release Solicitors
    • Retirement Property Conveyancing
    • Personal Injury Compensation
    • Medical Negligence Solicitors
  • Services for Business
    • Commercial Property
    • Commercial Property Disputes
    • Corporate & Commercial Legal Advice
    • Estate Management Solicitors
  • BLB Solicitors Locations
    • Almondsbury Solicitors
    • Bath Solicitors
    • Bristol Solicitors
    • Bradford on Avon Solicitors
    • Swindon Solicitors
    • Trowbridge Solicitors
  • About Us
    • Our Team
    • Working for BLB
    • BLB Solicitors – How we work
    • Making Payments to BLB Solicitors
    • Instructing BLB Solicitors
    • Terms of Business
    • Complaints Policy
    • Interest Policy
  • Blog
  • Contact Us

Home » The link between Onglyza and pancreatic cancer

Medical Negligence
Feb 4th, 2016

At BLB Solicitors, our goal is simple – to deliver you clear, practical legal advice and cost-effective solutions. We hope you enjoy exploring our Blog. If you can’t find what you’re looking for, please do contact us.

The link between Onglyza and pancreatic cancer

Many suffering from Diabetes will be acquainted with the drug Onglyza and some will have experienced serious side effects.

In 2013 the medical journal Diabetes published the results of a study that showed signs of pre-cancerous cell growth in people taking DPP-4 inhibitors, the class of drug to which Onglyza belongs. DPP-4 inhibitors increase the production and size of beta cells that produce insulin in the pancreas but according to the research these beta cells are abnormal. Evidence was also found of adenomas which are small tumours that can become malignant.

Pancreatic cancer can be difficult to detect and slow to respond to treatment unless found early. Common symptoms include back/abdomen pain, fatigue, unexplained weight loss and yellowing of the eyes and skin.

If you think you have developed pancreatic cancer as the result of taking Onglyza or have concerns about a late diagnosis of the condition by a health professional, call David Gazzard on 01793 615011.

David Gazzard
Request a Call Back

Recent Articles

  • Sodium valproate: the continuing scandal
  • Swindon medical negligence solicitor speaks out over report’s stark findings
  • Promising new test for sepsis wins big award
  • Sepsis compensation claim success
  • Medicines Review, to include Sodium Valproate, is underway

Newsletter Sign-up

* indicates required

Share this article

You may also like...
  • Apr 24th, 2018
    MHRA change licence for Sodium Valproate
    Read Article
  • Nov 22nd, 2018
    Sepsis compensation claim success
    Read Article
View All Related Articles
Get in-touch today
Contact Form

Left Column

Right Column

Centre

 
Sending
  • Bristol Solicitors

    0117 905 5308
  • Bath Solicitors

    01225 462871
  • Bradford on Avon Solicitors

    01225 866541
  • Swindon Solicitors

    01793 615011
  • Trowbridge Solicitors

    01225 755656
  • Almondsbury Solicitors

    0117 905 5308
Authorised & Regulated by Solicitors Regulation Authority (No. 636644)
©2025 BLB Solicitors | Terms | Privacy | Legal